Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004

Cerebral Hemispherectomy
Neurol 62:1712-1721,1664, Jonas,R.,et al, 2004

Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004

Marijuana Use and Epilepsy
Neurol 62:2095-2097, Gross,D.W.,et al, 2004

Recreational Use of Phenytoin, Marijuana, and Alcohol: A Case Report
Neurol 62:2330, Jessen,K., 2004

Seizure Outcomes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations
Neurol 63:683-687, Schauble,B.,et al, 2004

Monotherapy in Epilepsy
Arch Neurol 61:1361-1365, Vazquez,B., 2004

Rapid Infusion with Valproate Sodium is Well Tolerated in Patients with Epilepsy
Neurol 63:1507-1508, Wheless,J.W.,et al, 2004

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

Narcolepsy and Excessive Daytime Sleepiness
BMJ 329:724-728, Zeman,A.,et al, 2004

Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004

The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004

Caffeine as a Risk Factor for Chronic Daily Headache, A Population-Based Study
Neurol 63:2022-2027, Scher,A.I.,et al, 2004

Cardiac Arrhythmias in Focal Epilepsy: A Prospective Long-Term Study
Lancet 364:2212-2219,2157, Rugg,F.J.,et al, 2004

Practice Parameter: Pharmacological Treatment of Migraine Headache in Children and Adolescents
Neurol 63:2215-2224, Lewis,D.,et al, 2004

Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003

Severe Intoxication After Phenytoin Infusion: A Preventable Pharmacogenetic Adverse Reaction
Neurol 60:1395-1396, Citerio,G.,et al, 2003

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene ABCB1
NEJM 348:1442-1448,1480, Siddiqui,A.,et al, 2003

The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003

Lamotrigine for HIV-Associated Painful Sensory Neuropathies
Neurol 60:1508-1514, Simpson,D.M.,et al, 2003

Neonatal Epileptic Encephalopathy
Lancet 361:1614, Clayton,P.T.,et al, 2003

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Direct Access of Drugs to the Human Brain After Intranasal Drug Administration?
Neurol 60:1669-1671,1563, Merkus,P.,et al, 2003

Transient Lesion in the Splenium of the Corpus Callosum in an Epileptic Patient
Neurol 60:1838-1841, Mirsattari,S.M.,et al, 2003

Symptomatic SUNCT in an Eleven-Year-Old Girl
Neurol 60:2012-2013, Blattler,T.,et al, 2003

Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003

Intrathecal Baclofen for Stiff-Person Syndrome: Life-Threatening Intermittent Catheter Leakage
Neurol 60:1976-1978, Bardutzky,J.,et al, 2003

Stroke Associated with Sympathomimetics Contained in Over-the Counter Cough and Cold Drugs
Stroke 34:1667-1673, Cantu,C.,et al, 2003

Recent Advnaces in the Treatment of Epilepsy
Arch Neurol 60:929-935, Nguyen,D.K. &Spencer,S.S., 2003

A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003

Prolonged Treatment for Acute Symptomatic Refractory Status Epilepticus
Neurol 61:398-401, Sahin,M.,et al, 2003

Complementary/Alternative Medicine for Epilepsy in Arizona
Neurol 61:576-577, Sirven,J.I.,et al, 2003

Oral Contraceptives Reduce Lamotrigine Plasma Levels
Neurol 61:570-571, Sabers,A.,et al, 2003

Seizure Frequency is Associated with Age at Menopause in Women with Epilepsy
Neurol 61:451-455, Harden,C.L.,et al, 2003

Psychiatric Adverse Events During Levetiracetam Therapy
Neurol 61:704-706, Mula,M.,et al, 2003

Seizure Remission and Antiepileptic Drug Discontinuation in Children with Tuberous Sclerosis Complex
Arch Neurol 60:1286-1289, Sparagana,S.P.,et al, 2003

Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003

Discontinuation of Levetiracetam Because of Behavioral Side Effects
Neurol 61:1218-1221, White,J.R.,et al, 2003

Drug Points
BJM 327:905, Hadjikoutis,S.,et al, 2003

Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003

Hemispherectomy for Intractable Unihemispheric Epilepsy
Neurol 61:887-890, Kossoff,E.H.,et al, 2003

Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003

Seizure Exacerbation Associated with Oxcarbazepine in Idiopathic Focal Epilepsy of Childhood
Neurol 61:1012-1013, Chapman,K.,et al, 2003

Spinal Dural Arteriovenous Fistulas: Clinical Features in 80 Patients
JNNP 74:1438-1440, Jellema,K.,et al, 2003

Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003

Idiopathic Generalized Epilepsy and Choice of Antiepileptic Drugs
Neurol 61:1793-1795, Benbadis,S.R.,et al, 2003

Treatment Options for Trigeminal Neuralgia
BMJ 327:1360-1361, Merrison,A.F.A.,et al, 2003

Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003

Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003

Agitation by Sedation
Lancet 361:308, Tuohy,K.A.,et al, 2003